Business
IMVIONIX debuts with acquisition of BEOVU's North American rights
Biotech company launches to commercial space; secures U.S. and Canadian exclusive rights to the FDA-approved injection for wet AMD and DME.
Events
The Empire Forum debuts in NYC with full day of retina pipeline, industry, and investor talks
Co-chairs Rishi Singh, MD, and David Eichenbaum, MD, led the inaugural meeting, which is set to return in 2027.
Pipeline
VeonGen on track for phase 3 Stargardt trial after FDA meeting
Phase 1/2 trial data demonstrate favorable safety profile and BCVA improvements; company has met with the FDA to plan the phase 3 program.
Products
Scope launches OPTASE Heat Mask Pro for dry eye relief
New addition to the OPTASE product line of dry eye management solutions delivers targeted and symptomatic relief via Hydrobead moist heat technology.
Business
Newton launches all-in-one OD program, refreshes Founders Optical brand
Newton Preferred program offers technology, lenses, frames, financing, and pricing in a single vision care program for independent practices.
Research
Gout linked to worse diabetic retinopathy outcomes
Patients with T2D and gout had higher DR risk, while urate-lowering therapy was associated with lower risks of some adverse outcomes.
Business
Harrow debuts prescribing and access pharmacy platform
Company positions HarrowRx as a first-of-its-kind platform in the U.S. bringing prescribing, fulfillment, and patient support into one place for its entire branded portfolio.
Products
FDA orders NAION risk added to GLP-1 RA warning labels
Federal agency issues new safety warning following new evidence; will now require all manufactures to update medication labels.
Pipeline
Cloudbreak Pharma releases positive phase 3 topline data on pterygium therapy
Data demonstrate durable reductions in pterygium vascularity with a favorable safety profile; company intends to review findings with FDA.
Products
Eyedaptic launches AI visual assistant for smart glasses
Eva integrates with the E7 as a new category of intuitive and responsive assistive tech offering the ability to infer, reason, and take action in real time.
Research
Prenatal opioid exposure tied to poorer vision, attention in kids
Evidence also points to cognitive and educational difficulties that may become more apparent with age.
Pipeline
Glaukos and RevOpsis partner on retina tri-specific therapy development, commercialization
Exclusive licensing agreement also extends up to four retinal biologics.
Research
Dexamethasone eye drops may cut invasive ROP treatment in preterm infants
A 47% relative risk reduction fell short of statistical significance, but the safety data keep topical steroids in play as a noninvasive option.
Pipeline
Nacuity doses first patient in phase 3 trial on oral therapy for RP associated with Usher syndrome
Sites in the U.S. and Australia are actively enrolling patients for the SLO-RP Preserve trial.
Research
Simple OCT rule helps cut glaucoma false positives in myopia
Expert-derived OCT interpretation rules offer a practical way to reduce false-positive glaucoma diagnoses in myopic eyes.
Products
EyeDock debuts AI clinical assistant for ECPs
Online clinical reference and toolkit now comes with a virtual assistant for answering questions from a curated database of contact lenses, medications, conditions, and codes.
Research
Report: Rural residents face steep gap in retina care access
One in three rural Americans lives beyond an hour's drive of a retina specialist.
Pipeline
FDA grants Orphan Drug designation to Octant's RP oral therapy
Oral small molecule is designed to correct protein misfolding for RHO gene mutations, the root cause of RHO-adRP; phase 1/2 clinical study currently underway.
Business
Leadership watch: LENZ, CooperCompanies CEOs step down, among exec changes
Leadership changes are underway in the eyecare space—and we’ve got the latest.
Pipeline